HIF1A and neoplasm: HIF1-α is responsible for the upregulation of immunomodulatory surface ligands like cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed death ligand 1 (PD-L1), causing the inhibition of the anti-tumor immune responses [89].